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cause of back pain.
The patient was admitted for anemia and renal insufﬁciency. Her he-
moglobinwas 6.1 g/dL. BUN and creatininewere 31 and 3.3 respectively.
A renal ultrasound showedbilateral hydronephrosis. Nephrostomy tubes
were placed to relieve the obstructive nephropathy, with subsequent
improvement of kidney function.
Computed tomography scan of the pelvis revealed an enlarged, het-
erogenous uterus with the endometrial stripe measuring 32 mm. Com-
puted tomography of the chest revealed a lytic lesion of the scapula
measuring 11×9 cm and prominent right hilum of the lung [Fig. 1].Introduction
Endometrial carcinoma is the most common malignancy of the
female genital tract; an estimated 43,470 cases of endometrial carci-
nomawere diagnosed in 2010, with 7950 deaths from the malignancy
[1]. Vaginal bleeding is the initial symptom in 90% of patients. Bleeding
typically presents in the early stages of disease, leading to timely diag-
nosis and treatment. Endometrial carcinoma has an average 5 year
survival rate of 82.9%. Of endometrial carcinomas that metastasize,
less than 15%metastasize to bone [2]. In this case, we present a patient
diagnosed with endometrial carcinoma by biopsy of a scapular mass.Case presentation
A 77 year old post-menopausal African American woman pre-
sented to the emergency department with an acute exacerbation of
shoulder pain. Three months prior, she had noticed a right shoulder
mass. Shoulder and back pain had been progressively worsening for
several months. She reported weight loss of 90 lb during this time.
Due to severe deconditioning, she was unable to ambulate without
assistance. She had not sought medical care in 30 years. She reported
no other symptoms including postmenopausal bleeding. Physical
exam revealed a right scapular mass approximately 14 cm in size.e 304, Charleston, WV 25302,
-ND license.Pelvic ultrasound showed the uterine size to be 14×8×11 cm. Lytic le-
sionswere present in the right femoral head, left ilium, and vertebrae at
S1, L5, L3, and T7. A skeletal surveywas signiﬁcant for a lytic skull lesion.
Initially the differential diagnosis included multiple myeloma and
lymphoma. The most accessible site for biopsy was the scapula. This
biopsy revealed hemorrhagic metastatic villoglandular adenocarcino-
ma, suggestive of endometrial origin. The neoplastic cells were
strongly positive for estrogen and progesterone receptors. The patient
was diagnosed with FIGO stage IVb endometrial carcinoma. Paradox-
ically, with a trial of progestin, the patient developed vaginal bleeding
for the ﬁrst time since menopause. Palliative radiation to the right
scapula was given for pain control. The patient succumbed to her ill-
ness after receiving four fractions of radiation. This was within
1 month of diagnosis.
Case discussion
A review of the literature revealed no reported cases of endometrial
carcinoma metastatic to the scapula. This case report describes an
unusual presentation of endometrial carcinoma. Initially the index of
suspicion for endometrial cancer was low. Though the majority of
patients with endometrial cancer present with vaginal bleeding, there
remain a portion of cases which do not present in this manner. Elderly
women may not have bleeding because of cervical stenosis.
Confounding the diagnosis in this case were the widespread lytic
bone lesions. Bone metastasis occurs in less than 15% of women with
metastatic endometrial cancer [2]. Abdul-Karim et al. reported a 25%
incidence of osseous involvement based a retrospective review of
radiological ﬁndings and autopsy results. This included subclinical and
clinically evident osseous metastases [3].
This patient was initially found to have an extensive lytic lesion on a
radiograph, prompting further imaging with computed tomography.
Fig. 1. Scapular mass on CT of chest.
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process of staging to assess the tumor and involvement of surrounding
tissues. Positron emission tomography has the added beneﬁt of assisting
in the differentiation between benign andmalignant processes [4]. Bone
lesions also sometimes require biopsy to ascertain a pathologic diagnosis,
as illustrated by this case. Biopsy can be achieved with percutaneous or
open techniques. Excisional biopsy via an open technique is the gold
standard. However, percutaneous methods of ﬁne needle aspiration
and core biopsy provide cost-effective and accurate options for patholog-
ic evaluation of bone lesions. These techniques are particularly useful
when the mass has a soft tissue component [5].
Hematogenous spread is most commonly associated with lung
metastases, but bone, liver, and brain can also be affected. Of cases
metastatic to bone, the appendicular skeleton is the most common
site discussed in case reports. There appears to be a propensity for
lower extremity involvement, postulated by Albaredo et al. [2] to be
due to venous backﬂow. Simultaneous metastases to several bones,
as in our case, may be explained by tumor cell emboli in the systemic
circulation.An important factor in skeletal involvement is the histological
type. High grade lesions have been associated with an increase in
bony metastasis [3]. This patient was diagnosed with villoglandular
adenocarcinoma, which is a variant of endometrioid adenocarcinoma.
In comparison with endometrial adenocarcinoma, villoglandular ade-
nocarcinoma has similar rates of myometrial invasion and lymph
node metastasis [6].
This patient presented with FIGO stage IVb endometrial carcinoma
and was initially treated with progestin therapy. Other treatment op-
tions to include chemotherapy, radiation, and surgery may have been
feasible at a later time. This patient was a poor surgical candidate due
to deconditioning and severe malnutrition. This case brings to light
the concept that metastatic carcinoma can present with atypical
symptoms. This patient presented with apparent musculoskeletal ab-
normalities, found to be caused by malignant endometrial cancer.
This patient was biopsied at the most easily accessible site with unex-
pected results. Though this patient was unable to receive treatment
for her underlying condition, other cases described in the literature
have been able to receive life-prolonging treatment after diagnosis.
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